Drug Trial Radar · NCT05489328
Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age
Last checked: Nov 19, 2026Latest source record: Apr 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
394
Actual
Start
Aug 15, 2022
Primary completion
Oct 7, 2022
Study completion Oct 7, 2022
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 5, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 49 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to describe the safety and immunogenicity of Pneumococcal Conjugate Formulations in healthy adults 18 through 49 years of age.
Conditions
- Pneumococcal Disease
Interventions
Candidate-1Other
Biological
Candidate-2Other
Biological
Candidate-3Other
Biological
Candidate-4Other
Biological
Candidate-5Other
Biological
Candidate-6Other
Biological
Candidate ControlOther
Biological
13vPnCBiological
13-valent pneumococcal conjugate vaccine
PCV15Biological
15-valent pneumococcal conjugate vaccine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Local Reactions Within 7 Days After Administration of Study InterventionTime frame: Within 7 days after study intervention
- Percentage of Participants With Systemic Events Within 7 Days After Administration of Study InterventionTime frame: Within 7 days after study intervention
- Percentage of Participants With Adverse Events (AE) Within 1 Month After Administration of Study InterventionTime frame: Within 1 month after study intervention
- Percentage of Participants With Serious Adverse Events (SAE) Within 1 Month After Administration of Study InterventionTime frame: Within 1 month after study intervention
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Orange County Research Center
Tustin, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Clinical Research Consulting
Milford, Connecticut
Proactive Clinical Research,LLC
Fort Lauderdale, Florida
Indago Research & Health Center, Inc
Hialeah, Florida
Qps-Mra, Llc
South Miami, Florida
Centennial Medical Group
Elkridge, Maryland
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan
Prism Research LLC dba Nucleus Network
Saint Paul, Minnesota
South Jersey Infectious Disease
Somers Point, New Jersey
Accellacare - Wilmington
Wilmington, North Carolina
Clinical Trials of Texas, LLC
San Antonio, Texas
Diagnostics Research Group
San Antonio, Texas
IMA Clinical Research San Antonio
San Antonio, Texas
DM Clinical Research
Tomball, Texas
J. Lewis Research, Inc. / Foothill Family Clinic
Salt Lake City, Utah
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah
Alliance for Multispecialty Research, LLC
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.